EconPapers    
Economics at your fingertips  
 

Missing Diagnoses during the COVID-19 Pandemic: A Year in Review

Héctor Pifarré i Arolas, Josep Vidal-Alaball, Joan Gil, Francesc López, Catia Nicodemo and Marc Saez
Additional contact information
Josep Vidal-Alaball: Health Promotion in Rural Areas Research Group, Gerència Territorial de la Catalunya Central, Institut Català de la Salut, 08272 Barcelona, Spain
Francesc López: Centre for Research in Health Economics, Universitat Pompeu Fabra, 08002 Barcelona, Spain
Marc Saez: Research Group on Statistics, Econometrics and Health, Department of Economics, Universitat de Girona, 17004 Girona, Spain

IJERPH, 2021, vol. 18, issue 10, 1-10

Abstract: The COVID-19 pandemic has had major impacts on population health not only through COVID-positive cases, but also via the disruption of healthcare services, which in turn has impacted the diagnosis and treatment of all other diseases during this time. We study changes in all new registered diagnoses in ICD-10 groups during 2020 with respect to a 2019 baseline. We compare new diagnoses in 2019 and 2020 based on administrative records of the public primary health system in Central Catalonia, Spain, which cover over 400,000 patients and 3 million patient visits. We study the ratio of new diagnoses between 2019 and 2020 and find an average decline of 31.1% in new diagnoses, with substantial drops in April (61.1%), May (55.6%), and November (52%). Neoplasms experience the largest decline (49.7%), with heterogeneity in the magnitudes of the declines across different types of cancer diagnoses. While we find evidence of temporal variation in new diagnoses, reductions in diagnoses early in the year are not recouped by the year end. The observed decline in new diagnoses across all diagnosis groups suggest a large number of untreated and undetected cases across conditions. Our findings provide a year-end summary of the impact of the pandemic on healthcare activities and can help guide health authorities to design evidence-based plans to target under-diagnosed conditions in 2021.

Keywords: indirect impact; delayed diagnoses; COVID-19; SARS-CoV-2; access to healthcare (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/10/5335/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/10/5335/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:10:p:5335-:d:556293

Access Statistics for this article

IJERPH is currently edited by Ms. Veronica You

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2024-05-13
Handle: RePEc:gam:jijerp:v:18:y:2021:i:10:p:5335-:d:556293